SL
Insider
Sue-jean Lin
DirectorSue-jean Lin (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $778K of ARQT (25,272 sh × $30.78, as filed), executed Nov 24 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$898K
shares × price, as filed
Last traded
Jun 15
Filed Jun 17
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $898K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$121K4,946 sh × $24.38
Exec Jun 15
Filed Jun 17 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $778K
25,272 sh × $30.78
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET